SEC Form 4 · accession 0001127602-17-012624
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troyen A Brennan
Officer — EVP and Chief Medical Officer
Period of report
Mar 21, 2017
Accepted (ET)
Mar 22, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2017 | M | 16,637 | $45.07 | A | 94,309 | D | |
| Common StockF2 | Mar 21, 2017 | S | 16,637 | $78.73 | D | 77,672 | D | |
| Common StockF3 | Mar 21, 2017 | S | 7,212 | $78.73 | D | 70,460 | D | |
| Common Stock (restricted) | holding | — | — | — | 36,572 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4 | $45.07 | Mar 21, 2017 | M | 16,637 | D | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 16,637 | 0 | D |
| Stock OptionF5 | $54.53 | holding | — | — | — | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 23,604 | 23,604 | D |
| Stock OptionF6 | $74.29 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2021 | Common Stock | 54,550 | 54,550 | D |
| Stock OptionF7 | $102.26 | holding | — | — | — | Apr 1, 2016 | Apr 1, 2022 | Common Stock | 47,937 | 47,937 | D |
| Stock OptionF8 | $104.82 | holding | — | — | — | Apr 1, 2017 | Apr 1, 2023 | Common Stock | 53,772 | 53,772 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.30 and $79.00 per share.
- F3Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.32 and $79.00 per share.
- F4Option became exercisable in four equal annual installments, commencing 4/2/2013.
- F5Option became exercisable in four equal annual installments, commencing 4/1/2014.
- F6Option became exercisable in four equal annual installments, commencing 4/1/2015.
- F7Option became exercisable in four equal annual installments, commencing 4/1/2016.
- F8Option becomes exercisable in four equal annual installments, commencing 4/1/2017.